Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 29, 2015 10:38 AM ET

Pharmaceuticals

Company Overview of Angiogenix, Inc.

Executive Profile

Edmon R. Jennings

Chief Executive Officer and Director, Angiogenix, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
68--

Background

Mr. Edmon R. Jennings, also known as Ed, served as the Chief Executive Officer and President of Angiogenix Inc. from July 2003 to February 2008. Mr. Jennings served as Chief Commercialization Officer of Pain Therapeutics Inc., a medical research and development company, from February 2000 to June 2003. He was responsible for Pain Therapeutics' s business development, marketing and sales functions, as well as leading the development of its commercialization strategy. ...

Corporate Headquarters

500 Airport Boulevard
Burlingame, California 94010

United States

Phone: 650-579-6685
Fax: 650-579-6635

Board Members Memberships

Chief Executive Officer and Director
2012-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Audit Committee

Education

BA
University of Michigan

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Angiogenix, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.